Ignite Creation Date:
2025-12-24 @ 10:39 PM
Ignite Modification Date:
2025-12-31 @ 12:00 PM
Study NCT ID:
NCT01999335
Status:
TERMINATED
Last Update Posted:
2021-04-27
First Post:
2013-11-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04-25
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-25
First Submit QC Date:
None
Study First Post Date:
2013-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-02-23
Results First Submit QC Date:
None
Results First Post Date:
2021-04-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-31
Last Update Post Date:
2021-04-27
Last Update Post Date Type:
ACTUAL